Related Experiment Videos
[Immunologic parameters in patients with malignant melanoma]
Bratislavske Lekarske Listy
|December 1, 1989
Summary
This study investigated melanoma patients' immune responses using lymphocyte tests. Findings suggest these tests can evaluate immune reactivity and predict prognosis in melanoma.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Context:
- Malignant melanoma is a significant health concern.
- Understanding the immune system's role in melanoma is crucial for treatment and prognosis.
- Existing methods for assessing immune reactivity in cancer patients have limitations.
Purpose:
- To define the immunological reactivity of patients with malignant melanoma.
- To evaluate lymphocyte electrophoretic mobility and reactivity using poly-L-lysine agglutination and nucleolar tests.
- To correlate these immunological markers with disease progression and prognosis.
Summary:
- Lymphocyte tests, including poly-L-lysine agglutination and nucleolar tests, were performed on melanoma patients before and after tumor removal.
- Increased positive results in poly-L-lysine tests and altered lymphocyte electrophoretic mobility correlated with disease progression.
- Elevated nucleolar coefficients and active nucleoli indicated higher immune reactivity, while declining ring-shaped nucleoli suggested immunologic exhaustion.
Impact:
- The study provides valuable insights into the immunological status of melanoma patients.
- The findings suggest that these lymphocyte-based assays can be used to assess immune reactivity and predict outcomes in melanoma.
- This research may contribute to the development of more personalized treatment strategies for melanoma.